In addition, the NAFLD + AT + RSV group showed ameliorated dyslipidemia and decreased serum ALT and AST activities, indicating the hepatoprotective and hypolipidemic effects of AT and RSV. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.